Discontinuation report APO-NAPROXEN
| Report ID | 4734 |
| Drug Identification Number | 00522651 |
| Brand name | APO NAPROXEN TAB 250MG |
| Common or Proper name | NAPROXEN |
| Company Name | APOTEX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | NAPROXEN |
| Strength(s) | 250MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 1000 BTL |
| ATC code | M01AE |
| ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2017-05-31 |
| Actual discontinuation date | 2017-05-31 |
| Remaining supply date | 2016-12-31 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | APO-NAPROXEN 250 MG TAB 100 BTL & 500 BTL are available |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
| Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2017-03-30 | English | Compare |
| v2 | 2017-03-30 | French | Compare |
| v3 | 2017-03-30 | French | Compare |
| v4 | 2018-02-05 | English | Compare |
| v5 | 2018-02-05 | French | Compare |
Showing 1 to 5 of 5